Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
This clinical trial update notes the termination of the study evaluating the NantHealth GPS Cancer Test in patients with advanced cancers. T…
-
FDA approval · 2018-07-20FDA Approved: GEMCITABINE — Original Application (Sagent Pharmaceuticals)
FDA approves Sagent Pharmaceuticals' original ANDA for gemcitabine, a generic injectable chemotherapy used to treat several cancers.
-
CLINICAL_TRIALS research · 2018-07-18Clinical Trial Update: Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX
An observational retrospective study evaluating prognostic factors in advanced pancreatic cancer patients treated with the FOLFIRINOX regime…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study [Phase 2]
Phase II study evaluating preoperative FOLFIRINOX for resectable pancreatic cancer was terminated; results posted in 2018.
-
CLINICAL_TRIALS withdrawal · 2018-07-12Clinical Trial Update: Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene [Phase 2]
A phase 2 trial evaluating mitomycin-C in patients with advanced or recurrent pancreatic cancer harboring a BRCA2 mutation was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating gemcitabine and capecitabine with or without T-ChOS as adjuvant therapy for patients with resected pancreatic can…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating APN401 in patients with metastatic or unresectable melanoma, pancreatic cancer, renal cell carcinoma, and other sol…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer [NA]
This entry notes the completion of a clinical trial evaluating negative pressure therapy to prevent postoperative infection after surgery in…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) [Phase 1, Phase 2]
A Phase 1/2 trial of pembrolizumab plus chemotherapy in patients with various advanced cancers has been terminated.
-
CLINICAL_TRIALS withdrawal · 2018-07-02Clinical Trial Update: Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) [Phase 1, Phase 2]
The NivoPlus trial evaluating nivolumab plus chemotherapy in various advanced cancers has been terminated (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy [Phase 1]
This Phase 1 study of veliparib in patients with malignant solid tumors that did not respond to prior therapy has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome [NA]
This update reports results from a completed clinical trial investigating whether the tumor microenvironment of pancreatic cancer can predic…
-
CLINICAL_TRIALS research · 2018-06-27Clinical Trial Update: Incidence of POPF in the Resection of the Left Pancreas With RFAT
Clinical trial update evaluating the incidence of postoperative pancreatic fistula after resection of the left pancreas using RFAT; the tria…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers
A pan-European study comparing minimally invasive versus open pancreatoduodenectomy in high-volume centers has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer [Phase 2]
A Phase 2 trial comparing second-line oxaliplatin plus irinotecan versus irinotecan alone in pancreatic cancer refractory to gemcitabine and…
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of DMUC4064A in platinum-resistant ovarian cancer and unresectable pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer [Phase 2]
Phase 2 clinical trial of LY2495655 in pancreatic cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: New Treatment Option for Pancreatic Cancer [Phase 1]
A Phase 1 trial for a new treatment option in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer [Phase 2]
A Phase II neoadjuvant trial comparing Gemcitabine plus Nab-Paclitaxel versus modified FOLFIRINOX with SBRT for borderline resectable pancre…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Preoperative Nutritional Support in Malnutritional Cancer Patients [NA]
A completed clinical trial evaluated preoperative nutritional support in malnourished cancer patients, focusing on pancreatic and biliary ca…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of gemcitabine and celecoxib for pancreatic cancer after R0 resection; the study is curren…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Improving REsectability in Pancreatic NEoplasms (IRENE) [NA]
This entry provides an update on the IRENE clinical trial aimed at improving resectability in pancreatic neoplasms. It involves pancreatic c…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Yield Rate for Procurement the Histologic Core With Endoscopic Ultrasound-guided Fine Needle Biopsy With 20-gauge Ultrasound Biopsy Needles for Solid Pancreatic Masses: Pilot Study [NA]
This completed pilot trial from Yonsei University evaluates the yield rate of obtaining histologic core samples from solid pancreatic masses…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer [Phase 1]
This Phase 1 trial evaluated the combination of capecitabine and erlotinib with radiotherapy for non-operable advanced pancreatic cancer. Th…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: On-site Cytopathology EUS-FNA
This clinical trial update reports a completed study evaluating on-site cytopathology during EUS-FNA for pancreatic neoplasms and pancreatic…